Agencies Mankind Pharma, the drug maker, known for Manforce Condoms and Prega News, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for an initial public offering on Friday. According to bankers, the size of the public offer is expected to be Rs 5,500 crore.

Mankind's 43.26 billion rupees initial public offering (IPO) ranks as India's biggest so far in 2023, and is also the largest among Indian pharma companies to go public since Gland Pharma Ltd in 2020.

Shares of Mankind Pharma, a homegrown company that sells condom brand Manforce and pregnancy test kit Prega News, made a positive stock market debut on Tuesday with the stock listing at ₹1,300 on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), a 20.4% premium to its issue price of ₹1,080 per share.

Find IPO Date, Price, Live Subscription, Allotment, Grey Market Premium GMP, Listing Date, Analysis and Review. Get Mankind Pharma IPO details. Unlimited Trading + API @ ₹1999 PM

Introduction. The Mankind Pharma IPO will open on April 25 and close on April 27, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 4,326.36 crores through this public offering, consisting of 400 lakhs shares with a face value of ₹ 10 each, which will be issued at a price of ₹ 1026 to ₹ 1080 per share.

Mankind Pharma IPO shares were commanding a grey market premium (GMP) of Rs 90. The grey market is an unofficial platform for trading IPO shares. Mankind Pharma shares are expected to list with 8%.

MannKind Corporation (MNKD) Stock Price, News, Quote & History - Yahoo Finance MNKD - MannKind Corporation NasdaqGM - NasdaqGM Real Time Price. Currency in USD 4.0300 -0.0900 (-2.18%) At.

See the latest Anuh Pharma Ltd stock price (XBOM:506260), related news, valuation, dividends and more to help you make your investing decisions.

Company. Piramal Pharma Limited is an India-based company, which offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities. The Company has approximately 15 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS.

On Friday, the firm’s share price hit a 52-week high of Rs 595. GLS hopes to get a significant control premium of RS 700-720 per share, the report said. That amounts to a 22 per cent premium despite the stock appreciation. This surge in the stock price is a potential obstacle to the deal, the report quoted sources as saying. Also Read

Share Price Today: Check here live NSE/BSE today's stock price, intraday, monthly, yearly, share performance, returns, key metrics, financials, peer comparison, technicals, share holdings, mutual.

Gland Pharma Ltd. Share Price View in App BSE NSE 958.55 +7.30 0.8% 09 June 2023, 04:01:00 PM Volume: 745,313 980 970 960 09 AM 12 PM 03 PM 1D Low : 951.25 1D High : 989.05 1D 1W 1M 3M 6M 1Y 2Y 5Y Company Profile View details >> Gland Pharma Ltd. Delivery View details >> Delivered Qty Traded Qty BSE NSE Both